Establishment and characterization of a novel ‘double‐hit’ follicular lymphoma cell line, FL‐SJC
Open Access
- 27 May 2020
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (14), 7928-7938
- https://doi.org/10.1111/jcmm.15425
Abstract
About 5 per cent of follicular lymphoma (FL) cases are double‐hit (DH) lymphomas. Double‐hit follicular lymphoma (DHFL) cell lines can improve our understanding and drug development on FL. But there are only few DHFL cell lines. Here, we established a new MYC/BCL2 DHFL cell line, FL‐SJC. The cells were obtained from the hydrothorax of a patient with MYC/BCL2 DHFL and cultured for 140 passages in vitro. FL‐SJC cells demonstrated CD19++, CD20+, CD22++, HLA‐DR+, CD10+, CD38+, Lambda+ CD23‐, CD5‐ and Kappa‐. The chromosome karyotypic analysis confirmed the co‐existence of t(8;22)(q24;q11) and t(14;18)(q32;q21), as well as additional abnormalities involving chromosomes 2 and 3. Fluorescence in situ hybridization analysis (FISH) showed IGH/BCL2 fusion gene and the MYC rearrangement. In addition, the FL‐SJC cells displayed KMT2D/MLL2 and CREBBP gene mutations. After subcutaneous inoculation of FL‐SJC cells, the SCID mice developed solid tumour masses within 6‐8 weeks. FL‐SJC cells were proven to be free of Epstein‐Barr (EB) virus infection and be multidrug‐resistant. In a conclusion, the FL‐SJC cell line has been identified as a novel MYC/BCL2 double‐hit follicular lymphoma that can be used as a potentially available tool for the clinical and basic research, together with the drug development for MYC/BCL2 DHFL.Keywords
Funding Information
- National Natural Science Foundation of China-Yunnan Joint Fund (81700130)
This publication has 39 references indexed in Scilit:
- Double hit lymphoma: the MD Anderson Cancer Center clinical experienceBritish Journal of Haematology, 2014
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphomaNature, 2011
- Double-hit B-cell lymphomasBlood, 2011
- Establishment of a human herpes virus-8-negative malignant effusion lymphoma cell line (STR-428) carrying concurrent translocations of BCL2 and c-MYC genesLeukemia Research, 2007
- Knockdown of ALR (MLL2) Reveals ALR Target Genes and Leads to Alterations in Cell Adhesion and GrowthMolecular and Cellular Biology, 2007
- The c-Myc target gene networkSeminars in Cancer Biology, 2006
- CD5+ Follicular LymphomaAmerican Journal of Clinical Pathology, 2002
- Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1Leukemia, 2002
- Continuous hematopoietic cell lines as model systems for leukemia–lymphoma researchLeukemia Research, 2000
- Establishment and characterization of three new malignant lymphoid cell linesInternational Journal of Cancer, 1987